AR
AREV Life Sciences Global Corp
AREVF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $22.6K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.46x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 36.81%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 59.33%
Net margin 2,940.37%
Op. margin 2,827.74%
Quality
61 /100
Average ROIC 150.34%
ROA 571.63%
Asset turnover 0.19x
Debt
50 /100
Moderate Current ratio 0.06x
Int. coverage -236.17x
Net debt/EBITDA -0.02x
Stability
16 /100
Unstable Beta 4.94x
Rev. volatility 58.58%
EPS volatility 39.57%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AREVF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Michael C. Withrow
Employees
19,534
Headquarters
Coquitlam